由于老年人常伴有多种疾病及多器官的变化,且常服用多种药物,导致其接受抗栓治疗时发生出血性和缺血性事件的风险增加,但目前尚无更多针对老年人抗栓治疗的指南推荐。基于老年人群的特殊性,2015年7月,欧洲心脏病学会(ESC)血栓工作组发布了《老年人抗栓治疗专家意见书》,本文就该意见书进行阐述和解读,旨在为临床工作提供参考。 Because elderly people are often accompanied by a variety of diseases and multiple organ changes, and often take multiple drugs, leading to increased risk of hemorrhagic and ischemic events when receiving antithrombotic therapy, but no more for the elderly Guidelines for Antithrombotic Therapy Recommendations. Based on the particularity of the elderly population, in July 2015, the European Society of Cardiology (ESCT) Thrombosis Working Group released the “Expert Opinion on Antithrombotic Therapy for the Elderly,” which is described and interpreted in this paper to provide a platform for clinical work for reference.